| Related Knowledge Base Chapters|
| Journal Articles|
|Metabolic complications and treatment of perinatally HIV-infected children and adolescents|
Barlow-Mosha L, Eckard AR, McComsey GA, et al. J Int AIDS Soc. 2013 Jun 18;16:18600.
|Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study|
Petoumenos K, Worm SW, Fontas E, et al; D:A:D Study Group. J Int AIDS Soc. 2012 Oct 10;15(2):17426.
|Body composition and metabolic changes in HIV-infected patients|
Stanley TL, Grinspoon SK. J Infect Dis. 2012 Jun;205 Suppl 3:S383-90. Review.
|HIV medications: an update and review of metabolic complications|
Hester EK. Nutr Clin Pract. 2012 Feb;27(1):51-64. Review.
|Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings|
Musoke PM, Fergusson P. Am J Clin Nutr. 2011 Dec;94(6):1716S-1720S. Review.
|Management of the metabolic effects of HIV and HIV drugs|
Brown TT, Glesby MJ. Nat Rev Endocrinol. 2011 Sep 20;8(1):11-21. Review.
|The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection|
Paik IJ, Kotler DP. Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):469-78. Review.
|HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies|
Falutz J. Curr Opin Clin Nutr Metab Care. 2011 May;14(3):255-60. Review.
|Dyslipidemia and its treatment in HIV infection|
Grunfeld C. Top HIV Med. 2010 Aug-Sep;18(3):112-8. Review.
|Switching antiretroviral therapy to minimize metabolic complications|
Lake JE, Currier JS. HIV Ther. 2010 Nov;4(6):693-711.
|Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment|
Haubrich RH, Riddler SA, DiRienzo AG, et al; AIDS Clinical Trials Group (ACTG) A5142 Study Team. AIDS. 2009 Jun 1;23(9):1109-18.
|Integrating Nutrition Therapy into Medical Management of Human Immunodeficiency Virus |
Clinical Infectious Diseases (supplement), April 1, 2003. Special issue of CID, with articles devoted to HIV-related nutritional issues and metabolic abnormalities.
| Guidelines and Best Practices|
| Conference Reports and Proceedings|
| Presentations, Interviews, and Roundtable Discussions|
|Metabolic Complications of HIV (and Antiretroviral Therapy)|
New York State Department of Health AIDS Institute, Clinical Education Initiative; November 2012.
An online video learning module presented by Dr. Marshall Glesby, MD, PhD.
|Co-Morbidities and Metabolic Complications in HIV|
A 20-minute video presentation of a panel discussion at the 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle. Panelists include Michael Dubé, MD; Edgar Turner Overton, MD; David Alain Wohl, MD; and Ronald T. Mitsuyasu, MD. Moderated by Jeff Taylor. From the IFARAblog.org website.
|Metabolic Complications and Aging in HIV|
New England AIDS Education and Training Center; September 2011. [PDF, 2.73MB]
A presentation given by Steven Grinspoon, MD, at the 6th National Conference on HIV/AIDS and Aging Symposium in Boston.
| Online Books and Chapters|
| Provider Education and Training|
| Slide Sets|
|AIDSinfo Drug Database|
U.S. Department of Health and Human Services (DHHS) project providing information on antiretroviral treatment and drugs that treat or prevent AIDS-related illness.
Succinct, easy-to-read information on HIV drugs and related issues.
|Anti-HIV/OI/TB Therapeutics Database|
Computerized databases containing chemical structures and biological data established at the Division of AIDS (DAIDS) of NIAID to foster developments in the chemotherapy of HIV, opportunistic infections, and tuberculosis and to serve as an information source.
|Database of Antiretroviral Drug Interactions |
Search by antiretroviral drug, interacting drug, or interacting drug class. Maintained by HIV InSite.
Site features information on interactions with each class of antiretroviral drugs. Maintained by the Liverpool HIV Pharmacology Group, University of Liverpool.
|HIV Medication Guide|
Features information on single- and multiple-HIV drug interactions, a customizable medication chart function, patient drug pamphlets, and more. Available in English and French from JAG enterprises, a clinical pharmacy consultation firm.
|Johns Hopkins HIV Guide|
An on-line decision support tool designed to assist clinicians in the diagnosis, management and treatment of HIV/AIDS. Requires registration.
|NIAID/DAIDS: HIV/AIDS Treatment|
An easy-to-read site with a comprehensive overview of the discovery and development of AIDS therapeutics, from the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID).
|Toronto General Hospital Immunodeficiency Clinic|
HIV treatment resources, including drug interactions tables, fact sheets, and other information for health care professionals.
Up-to-date, peer reviewed, clinically-relevant information on all U.S. drugs, as well as off-label uses and dosages, herbal supplements, nutritional products, and new and investigational drugs. Requires paid subscription.
|Cytochrome P450 Drug Interaction Table|
Designed as a hypothesis testing, teaching, and reference tool for physicians and researchers interested in drug interactions that are the result of competition for, or effects on the human cytochrome P450 system. Includes links to canned PubMed searches.
|FDA Center for Drug Evaluation and Research|
(CDER) Reports and information on prescription and over-the-counter drugs, as well as regulatory issues and the drug approval process, public health alerts, and more.
Physicians' Desk Reference online, featuring drug and healthcare information, with separate interfaces for physicians, pharmacists, physician assistants, nurses, and consumers. Registration is required, and is either free or fee-based, depending on the level of access desired.
Index of information on pharmaceutical products from WebMD. Features search function for looking up drugs by the pill imprint code, color, or shape.
| Adverse Event Reporting and Emergencies|
|American Association of Poison Control Centers|
List of poison control centers.
|Antiretroviral Pregnancy Registry|
Intended to provide an early signal of any major teratogenic effect associated with a prenatal exposure to the products monitored through the registry, a voluntary prospective, exposure-registration, observational study designed to collect and evaluate data on the outcomes of pregnancy exposures to antiretroviral products.
FDA safety information and adverse event reporting program for drugs and other medical products.
|U.S. Pharmacopeial Convention|
A scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide.
|Vaccine Adverse Event Reporting System|
(VAERS) Vaccine surveillance program of the FDA Center for Biologics Evaluation and Research.